[Generalized candida mycoses].
D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D002056:Burns / Q000150:complications; D002176:Candida albicans / Q000302:isolation & purification*; D002177:Candidiasis / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000635:transmission; D002404:Catheterization / Q000009:adverse effects; D002493:Central Nervous System Diseases / Q000382:microbiology; D048909:Diabetes Complications; D003937:Diagnosis, Differential; D005455:Fluorescent Antibody Technique; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007153:Immunologic Deficiency Syndromes; D007165:Immunosuppression Therapy; D008172:Lung Diseases, Fungal / Q000175:diagnosis; D009761:Nystatin / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis; D011704:Pyelonephritis / Q000382:microbiology; D012130:Respiratory Hypersensitivity / Q000175:diagnosis; D018805:Sepsis / Q000209:etiology; D012698:Serologic Tests
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D009761:Nystatin; D000666:Amphotericin B; D005472:Fluorouracil
Generalisierte Candida-Mykosen